On the occasion of the Rare Diseases Day, our CEO, Meritxell Teixidó, was interviewed by Mari Cruz Hernández Gibert on the “LLETRA LLIGADA” program on Ràdio 4.
In this interview “Technology closer to young patients”, Meritxell explains how G2B offers a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare pediatric cancer indications such as DIPG. She tells us about the importance of working closely with patients and families. Why she considers that groups such as the KIDS of the Sant Joan de Déu Hospital are necessary for any research project in the field of pediatrics and what it brings her on a personal level to work with this project.
A radio meeting she had the privilege of sharing with Ricard Casanova, a member of KIDS Barcelona and brother of a patient who died of DIPG. A bright young man and a big fan of LEGO who has devised an augmentative communication keyboard in order to help children with illnesses or communication difficulties. An example that regroups many values.
The key is not only to continue researching therapeutic innovation to find cures for these diseases, but also to continue searching, as Ricard does, for ways to provide better care for these patients and their families.
Bringing medicines and care beyond barriers!